# US 2021/0069378 A1 · Nanocellulose-containing bioinks for 3d bioprinting, methods of making and using the same, and 3d biostructures obtained therefrom

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0069378 A1
- Document ID: US20210069378A1
- Status: Published application
- Kind: A1
- Application number: 16/976,803
- Filed: 2019-03-07
- Published: 2021-03-11
- Earliest claimed: 2018-03-07
- Assignees: GranBio Intellectual Property Holdings, LLC; Regeninx Limited
- Applicants: GranBio Intellectual Property Holdings, LLC; Regeninx Limited
- Inventors: Kimberly NELSON; Iain S. WHITAKER; Zita M. JESSOP; Ayesha AL-SABAH
- Web page: https://patentgrep.com/patent/US20210069378A1

## CPC

- A61L 27/26: Mixtures of macromolecular compounds
- A61L 27/48: with macromolecular fillers
- A61L 27/3683: {subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment}
- A61L 27/3817: {Cartilage-forming cells, e.g. pre-chondrocytes}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- B33Y 70/00: Materials specially adapted for additive manufacturing
- B33Y 80/00: Products made by additive manufacturing
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61L 2430/06: for cartilage reconstruction, e.g. meniscus
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B33Y: ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING

## Abstract

Some variations of the invention provide a bioink composition for 3D bioprinting, comprising: nanocellulose in the form of nanocellulose crystals, nanocellulose fibrils, or preferably a combination thereof; alginate that is ionically crosslinkable in the presence of an ionic crosslinking agent; and water. The nanocellulose-alginate bioinks have favorable rheological, swelling, and biocompatibility properties for extrusion-based bioprinting. It is experimentally demonstrated that nanocellulose-alginate bioinks with human nasoseptal chondrocytes enable cartilage bioprinting at high resolution. The disclosed nanocellulose has been proven to be compatible with cell survival and proliferation; to possess nanoscale and microscale architectures mimicking the native extracellular environment, encouraging differentiation and tissue formation; and to have ideal rheological properties to allow extrusion 3D bioprinting. Bioink with a unique blend of crystal and fibril nanocellulose produces a very stable construct volume in culture.

## Claims

### Claim 1

A bioink composition for 3D bioprinting, said bioink composition comprising:
(a) nanocellulose in the form of a combination of nanocellulose crystals and nanocellulose fibrils;
(b) alginate in the form of alginic acid and/or an alginate salt; and
(c) water,
wherein said alginate is ionically crosslinkable in the presence of an ionic crosslinking agent.

### Claim 2

A bioink composition for 3D bioprinting, said bioink composition comprising:
(a) nanocellulose in the form of nanocellulose fibrils, wherein said nanocellulose is characterized by a thermal-decomposition onset temperature of at least 240° C.;
(b) alginate in the form of alginic acid and/or an alginate salt; and
(c) water,
wherein said alginate is ionically crosslinkable in the presence of an ionic crosslinking agent.

### Claim 3

A bioink composition for 3D bioprinting, said bioink composition comprising:
(a) nanocellulose in the form of a nanocellulose crystals, wherein said nanocellulose is characterized by a thermal-decomposition onset temperature of at least 290° C.;
(b) alginate in the form of alginic acid and/or an alginate salt; and
(c) water,
wherein said alginate is ionically crosslinkable in the presence of an ionic crosslinking agent.

### Claim 4 (depends on 1)

The bioink composition of claim 1, wherein said nanocellulose is present at a nanocellulose concentration from 1% (w/v) to 10% (w/v).

### Claim 5 (depends on 4)

The bioink composition of claim 4, wherein said nanocellulose is present at a nanocellulose concentration from 3% (w/v) to 6% (w/v).

### Claim 6 (depends on 1)

The bioink composition of claim 1, wherein said alginate is present at an alginate concentration from 0.1% (w/v) to 5% (w/v).

### Claim 7 (depends on 1)

The bioink composition of claim 1, wherein said bioink composition is a cell-free bioink.

### Claim 8 (depends on 1)

The bioink composition of claim 1, wherein said bioink composition is a cell-laden bioink containing viable human cells, and wherein said viable human cells are optionally human nasoseptal chondrocytes.

### Claim 9

(canceled)

### Claim 10 (depends on 1)

The bioink composition of claim 1, wherein said nanocellulose is hydrophilic nanocellulose.

### Claim 11 (depends on 1)

The bioink composition of claim 1, wherein said nanocellulose is characterized by a thermal-decomposition onset temperature of at least 250° C.

### Claim 12 (depends on 11)

The bioink composition of claim 11, wherein said thermal-decomposition onset temperature is at least 290° C.

### Claim 13 (depends on 2)

The bioink composition of claim 2, wherein said thermal-decomposition onset temperature is at least 270° C.

### Claim 14 (depends on 3)

The bioink composition of claim 3, wherein said thermal-decomposition onset temperature is at least 310° C.

### Claim 15 (depends on 1)

The bioink composition of claim 1, wherein said nanocellulose contains less than 0.05 wt % sulfur.

### Claim 16 (depends on 1)

The bioink composition of claim 1, wherein said nanocellulose contains no sulfate half-ester groups.

### Claim 17 (depends on 1)

The bioink composition of claim 1, wherein said nanocellulose has a zeta potential of at least −20 mV or more negative.

### Claim 18 (depends on 1)

The bioink composition of claim 1, wherein said nanocellulose is shear-thinning.

### Claim at position 19

19-20. (canceled)

### Claim 21 (depends on 1)

The bioink composition of claim 1, wherein said bioink composition further comprises an ionic crosslinking agent, and wherein said ionic crosslinking agent optionally includes a divalent cation selected from the group consisting of Ca2+, Sr2+, Ba2+, and combinations thereof.

### Claim at position 21

22-23. (canceled)

### Claim 24 (depends on 1)

The bioink composition of claim 1, said bioink composition further comprising one or more bioink additives selected from the group consisting of growth promoters, growth factors, vitamins, minerals, enzymes, proteins, sugars, sugar alcohols, acids, bases, salts, buffers, stabilizers, dissolved oxygen, and antibiotics.

### Claim 25 (depends on 1)

The bioink composition of claim 1, wherein said bioink composition is non-cytotoxic to human cells.

### Claim at position 24

26-50. (canceled)
